Radiology Doctors in Thibodaux, LA Accepting Medicare

5 Radiology doctors found. Showing 1 - 5

Mrs. Holly Merrill Leger, RVT Radiology - Diagnostic Ultrasound Medicare: Not Enrolled in Medicare Practice Location: 320 Cascade Dr, Thibodaux, LA 70301 Phone: 985-413-9770

Dr. Gregory Dobard, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 602 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-447-5500

Mrs. Casey Rowden Duncan, RCS Radiology - Diagnostic Ultrasound Medicare: Not Enrolled in Medicare Practice Location: 603 Jackson St, Thibodaux, LA 70301 Phone: 985-381-6451    Fax: 985-274-8771

Carlos R Gimenez, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 602 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-447-5500

Blain C Arthurs, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 602 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-447-5500

News Archive

TeleForum to discuss H1N1 precautions on campus

In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.

Change in gene may be underlying molecular defect in some colorectal cancers

Inactivation of a DNA repair gene may be an early step in the development of sporadic colorectal tumors, and detection of the molecular basis for this inactivation may ultimately be useful in risk assessment for colorectal cancer, according to a new study in the September 21 issue of the Journal of the National Cancer Institute.

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.

Sen. Graham gun bill would bar more with mental illness from buying guns

Three senators potentially facing tough re-election challenges next year introduced NRA-endorsed legislation Wednesday that would bar more people from buying guns due to mental illness.

Research demonstrates a safe method to control malaria in Africa

Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world.

Read more Medical News

› Verified 5 days ago